Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG1 (AM359b) (MALS verified) | SPD-M265-1mg

Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG1 (AM359b) (MALS verified) | SPD-M265-1mg| Gentaur Distribution US, UK & Europe

It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Source: The antibody is isolated from the serum of COVIDN/A19 vaccine recipient and is recombinantly produced from human 293 cells (HEK293) . This antibody can broadly neutralize SARSN/ACoVN/A2 Variants of Concerns (VOCs) including Alpha, Beta, Gamma, Delta and Omicron. .

Molecule: Spike RBD.

Species: Human.

Tag: Human IgG1 | Human Kappa.

Conjugate: Unconjugated.

Purity: 95%.

Charactirization: PBS, pH7.4.

Storage Conditions: -20℃.

Shipping Conditions: RT